Beta-Hemolytic Streptococci as Human Pathogens
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Bacterial Pathogens".
Deadline for manuscript submissions: closed (31 October 2021) | Viewed by 13768
Special Issue Editor
Special Issue Information
Dear Colleagues,
Beta-hemolytic streptococci are important human pathogens, creating a high burden of disease worldwide. Although still sensitive to some antibiotics, they cause an array of serious pyogenic infections and non-suppurative sequelae, e.g., rheumatic fever and rheumatic heart disease. The development of vaccines is still in progress and they are not yet available on the market. Beta-hemolytic streptococci are also important animal pathogens and some of those can cause zoonotic diseases.
This Special Issue of Pathogens will focus on three important (generally) beta-hemolytic streptococcal species found in humans: 1. Streptococcus pyogenes (commonly also termed the “group A streptococcus” or “GAS”), 2. Streptococcus dysgalactiae subsp. equisimilis (the “groups C and G streptococci—GCS, GGS”), and 3. Streptococcus agalactiae (group B streptococcus).
The scope of the contributions will be on the basics of the microbiology of these bacteria including important pathogenicity factors and their regulation, the diseases they cause in man and their epidemiology, and aspects of therapy and prevention of these diseases.
Thus, it will serve as a concise and up-to-date overview of these human pathogens, the role they play in human infections, and the management of the illnesses. More elaborate and detailed overviews are found in recent publications by Ferretti, J. J. et al. [1] and Fischetti, V. A. et al. [2].
References:
- Ferretti JJ, Stevens DL, Fischetti VA. Streptococcus pyogenes: Basic Biology to Clinical Manifestations [electronic book]. Oklahoma City (OK): University of Oklahoma Health Sciences Center; 2016. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26866208.
- Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Braunstein M, Rood JI, editors. Gram-Positive Pathogens. 3rd ed. Washington, DC: American Society for Microbiology; 2019.
Prof. Rudolf Lütticken
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Streptococcus pyogenes;
- S. dysgalactiae;
- S. agalactiae;
- streptococcal infections;
- prevention;
- therapy.
